Biotech · Private company
Oxford Immunotec
Track this companyFree. Adds Oxford Immunotec to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- T-Cell SelectTM KitTuberculosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)COMPLETED · started Nov 4, 2019ClinicalTrials.gov NCT04141982 · fetched Nov 12, 2026
- Assessing the Ability of the T-SPOT®.TB Test (IQ)COMPLETED · started Sep 23, 2019ClinicalTrials.gov NCT03973970 · fetched Nov 12, 2026
- T-SPOT.CMV and T-SPOT.PRT Diagnostic AssaysCOMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02382211 · fetched Nov 12, 2026